mibolerone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| anabolic steroids | 5578 | 3704-09-4 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
prevents estrus in animals prevents experimental lymphoid leukosis
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:50113 | androgene |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Dogs | Prevention of estrus | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Cheque Drops | Zoetis Inc. | 1 |
| Cheque Medicated Dog Food | Zoetis Inc. | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Androgen receptor | Nuclear hormone receptor | AGONIST | IC50 | 8.96 | IUPHAR | ||||
| Androgen receptor | Transcription factor | AGONIST | IC50 | 8.80 | IUPHAR |
External reference:
| ID | Source |
|---|---|
| CHEBI:34849 | CHEBI |
| CHEMBL425863 | ChEMBL_ID |
| C100075 | MESH_SUPPLEMENTAL_RECORD_UI |
| 2859 | IUPHAR_LIGAND_ID |
| DB11429 | DRUGBANK_ID |
| C0066502 | UMLSCUI |
| 3203 | INN_ID |
| 96342004 | SNOMEDCT_US |
| 3704-09-4 | SECONDARY_CAS_RN |
| D05025 | KEGG_DRUG |
| 251636 | PUBCHEM_CID |
| NOCODE | MMSL |
| 9OGY4BOR8D | UNII |
Pharmaceutical products:
None